Kymera Therapeutics Inc Capital Reinvestment Ratio
Kymera Therapeutics Inc capital reinvestment ratio. Kymera Therapeutics Inc (KYMR) has a Capital Reinvestment Ratio of 1.44x as of December 2023, meaning it reinvests 1% of its operating cash flow ($8.04 Million) in capital expenditures ($11.62 Million). Check cash flow reinvestment rate of Kymera Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Kymera Therapeutics Inc (2019–2020)
Capital reinvestment ratio of Kymera Therapeutics Inc from 2019 to 2020. This chart tracks Kymera Therapeutics Inc's Capital Reinvestment Ratio across 2 annual periods. Also explore KYMR shareholders equity momentum to track the company's year-over-year net asset growth rate.
Kymera Therapeutics Inc Capital Reinvestment Ratio by Year (2019–2020)
Kymera Therapeutics Inc capital reinvestment ratio by year from 2019 to 2020. For the full cash flow conversion analysis, see how efficiently does Kymera Therapeutics Inc generate cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.10x | $88.13 Million | $9.10 Million | ▲ +247.4% |
| 2019 | 0.03x | $17.91 Million | $532.00K | — |